Education
About Us
Working with TipRanks
Follow Us
Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 18.72M | $ 31.25M | $ 29.75M | $ 6.76M | $ 6.48M |
| Gross Profit | $ 15.93M | $ 13.17M | $ 17.79M | $ 2.05M | $ 1.35M |
| Operating Income | $ -141.93M | $ -97.36M | $ -89.85M | $ -89.72M | $ -50.91M |
| EBITDA | $ -51.72M | $ -115.45M | $ -84.36M | $ -64.46M | $ -47.20M |
| Net Income | $ -132.06M | $ -88.48M | $ -86.91M | $ -90.86M | $ -51.02M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 113.59M | $ 119.11M | $ 217.57M | $ 191.41M | $ 54.13M |
| Total Assets | $ 220.33M | $ 197.41M | $ 254.60M | $ 251.21M | $ 70.78M |
| Total Debt | $ 0.00 | $ 426.00K | $ 684.00K | $ 693.00K | $ 11.26M |
| Net Debt | $ -24.57M | $ -39.45M | $ -44.59M | $ -26.66M | $ -10.81M |
| Total Liabilities | $ 64.77M | $ 40.23M | $ 56.98M | $ 53.87M | $ 33.13M |
| Stockholders' Equity | $ 155.55M | $ 157.18M | $ 197.62M | $ 197.34M | $ 37.65M |
| Cash Flow | |||||
| Free Cash Flow | $ -20.20M | $ -79.63M | $ -68.17M | $ -52.44M | $ -39.09M |
| Operating Cash Flow | $ -20.07M | $ -78.33M | $ -67.57M | $ -52.13M | $ -38.63M |
| Investing Cash Flow | $ -69.77M | $ 46.22M | $ 12.63M | $ -167.63M | $ 6.39M |
| Financing Cash Flow | $ 74.54M | $ 26.71M | $ 72.87M | $ 225.05M | $ 18.37M |